Signal de tendance

Évolution des mentions ✨ Nouveau
30j7jMaintenant

9

mentions (7j)

9

mentions (30j)

11 juin 2026

premier signal

1

pays concernés

Contexte et analyse

Cette tendance "Supreme Court unanimous decision in Hikma v. Amarin skinny‑label case" a été détectée dans la catégorie Droit & Juridique avec un score de 100/100. Cette tendance connaît une croissance explosive et attire beaucoup d'attention actuellement.

Entités liées

https://law.marquette.edu/facultyblog/2026/06/the-skinny-label-case-a-unanimous-supreme-court-sides-with-the-generic/https://www.fiercepharma.com/pharma/its-unanimous-scotus-agrees-hikma-skinny-label-case-vs-amarinhttps://www.mintz.com/insights-center/viewpoints/2231/2026-06-05-supreme-court-clarifies-standard-induced-infringementhttps://www.jdsupra.com/legalnews/supreme-court-reverses-federal-circuit-9382788/https://www.bipc.com/supreme-court-greenlights-skinny-labels-in-hikma-v-amarinhttps://natlawreview.com/article/supreme-court-hands-generics-unanimous-win-skinny-labels-hikma-v-amarinhttps://www.steptoe.com/en/news-publications/step-into-ip-blog/supreme-court-reinforces-inducement-pleading-standard-reversing-federal-circuit-in-skinny-label-case.htmlhttps://ipwatchdog.com/2026/06/07/readers-react-what-expect-after-supreme-courts-hikma-ruling/https://www.msn.com/en-us/news/insight/supreme-court-unanimously-backs-hikma-in-skinny-label-case/gm-GMBC6A178A?gemSnapshotKey=GMBC6A178A-snapshot-41&ocid=finance-verthp-feeds

Extraits des sources

* Post author: * Post published:June 4, 2026 * Post category:/// * Post comments: ](https://law.marquette.edu/facultyblog/wp-content/uploads/2011/12/Supreme-Court1.jpg)Just this morning, the Supreme Court issued its , the most recent “skinny-label” case, and it did so unanimously. Justice Jackson, writing for all nine, reversed the Federal Circuit and held that Amarin’s lawsuit against the generic manufacturer Hikma cannot survive a motion to dismiss. I had planned to spread this story across a...

— law.marquette.edu

Ce que disent les sources

  • "The Supreme Court issued a unanimous opinion reversing the Federal Circuit and held that Amarin's lawsuit against generic manufacturer Hikma cannot survive a motion to dismiss."

    law.marquette.edu

  • "With a resounding unanimous vote, the U.S. Supreme Court has sided with Hikma Pharmaceuticals, ruling that its generic version of Amarin's fish oil-derived..."

    fiercepharma.com

  • "By Siegmund Gutman, T.O. Kong, David M. Hanna, Richard G. Gervase, Jr., Adam P. Samansky, Peter J. Cuomo, Daniela Glaser, Frances Senn. In a unanimous..."

    mintz.com

  • "Today, the U.S. Supreme Court issued its decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No. 24-889, unanimously reversing the..."

    jdsupra.com

  • "On June 4, 2026, the Supreme Court published a long-awaited decision providing guidance to the pharmaceutical industry on the status of so-called “skinny..."

    bipc.com

  • "A unanimous Supreme Court held that Amarin did not plausibly allege that Hikma's skinny label and marketing actively induced infringement of Vascepa's..."

    natlawreview.com

  • "The Supreme Court today issued its decision in Hikma v. Amarin (Case No. 24-889). In a 9-0 opinion authored by Justice Ketanji Brown Jackson, the Court."

    steptoe.com

  • "Below, stakeholders weigh in on the upshot of the ruling and what it means for pharmaceutical innovation going forward."

    ipwatchdog.com

  • "Unanimous SCOTUS ruling: The Court voted 9-0 to reverse the Federal Circuit, finding Amarin's claims against Hikma lacked plausible allegations of active..."

    msn.com

Partager cette tendance

X LinkedIn